Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;57 Suppl 2:S129-37.
doi: 10.1093/cid/cit302.

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Affiliations

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Geert Robaeys et al. Clin Infect Dis. .

Abstract

In the developed world, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden of HCV-related liver disease in this group is increasing, but treatment uptake among PWID remains low. Among PWID, there are a number of barriers to care that should be considered and systematically addressed, but these barriers should not exclude PWID from HCV treatment. Furthermore, it has been clearly demonstrated that HCV treatment is safe and effective across a broad range of multidisciplinary healthcare settings. Given the burden of HCV-related disease among PWID, strategies to enhance HCV assessment and treatment in this group are urgently needed. These recommendations demonstrate that treatment among PWID is feasible and provides a framework for HCV assessment, management, and treatment. Further research is needed to evaluate strategies to enhance assessment, adherence, and SVR among PWID, particularly as new treatments for HCV infection become available.

Keywords: HCV; HIV; drug users; guidelines; injecting; injection.

Similar articles

See all similar articles

Cited by 44 articles

See all "Cited by" articles

MeSH terms

Substances

Feedback